Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965937109> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W1965937109 endingPage "119" @default.
- W1965937109 startingPage "109" @default.
- W1965937109 abstract "In a limited area on the southwest coast of Taiwan, where artesian well water with a high concentration of arsenic has been used for more than 60 years, a high prevalence of chronic arsenicism has been observed in recent years. The total population of this “endemic” area is approximately 100,000. A general survey of 40,421 inhabitants and follow-up of 1,108 patients with blackfoot disease were made. Blackfoot disease, so-termed locally, is a peripheral vascular disorder resulting in gangrene of the extremities, especially the feet. The overall prevalence rates for skin cancer was 10.6 per 1000, and for blackfoot disease 8.9 per 1000. Generally speaking, the prevalence increased steadily with age in both diseases. The prevalence rates for skin cancer and blackfoot disease increased with the arsenic content of well water, i.e., the higher the arsenic content, the more patients with skin cancer and blackfoot disease. A dose–response relationship between blackfoot disease and the duration of water intake was also noted. Furthermore, the degree of permanent impairment of function in the patient was directly related to duration of intake of arsenical water and to duration of such intake at the time of onset. The most common cause of death in the patients with skin cancer and blackfoot disease was carcinoma of various sites. The 5-year survival rate after the onset of blackfoot disease was 76.3%; the 10-year survival rate was 63.3% and 15-year survival rate, 52.2%. The 50% survival point was 16 years after onset of the disease." @default.
- W1965937109 created "2016-06-24" @default.
- W1965937109 creator A5025176777 @default.
- W1965937109 date "1977-08-01" @default.
- W1965937109 modified "2023-10-14" @default.
- W1965937109 title "Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic" @default.
- W1965937109 cites W2006920617 @default.
- W1965937109 cites W2011839012 @default.
- W1965937109 cites W2016926113 @default.
- W1965937109 cites W2020506125 @default.
- W1965937109 cites W2078627975 @default.
- W1965937109 doi "https://doi.org/10.1289/ehp.7719109" @default.
- W1965937109 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1637425" @default.
- W1965937109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/908285" @default.
- W1965937109 hasPublicationYear "1977" @default.
- W1965937109 type Work @default.
- W1965937109 sameAs 1965937109 @default.
- W1965937109 citedByCount "663" @default.
- W1965937109 countsByYear W19659371092012 @default.
- W1965937109 countsByYear W19659371092013 @default.
- W1965937109 countsByYear W19659371092014 @default.
- W1965937109 countsByYear W19659371092015 @default.
- W1965937109 countsByYear W19659371092016 @default.
- W1965937109 countsByYear W19659371092017 @default.
- W1965937109 countsByYear W19659371092018 @default.
- W1965937109 countsByYear W19659371092019 @default.
- W1965937109 countsByYear W19659371092020 @default.
- W1965937109 countsByYear W19659371092021 @default.
- W1965937109 countsByYear W19659371092022 @default.
- W1965937109 countsByYear W19659371092023 @default.
- W1965937109 crossrefType "journal-article" @default.
- W1965937109 hasAuthorship W1965937109A5025176777 @default.
- W1965937109 hasBestOaLocation W19659371091 @default.
- W1965937109 hasConcept C121608353 @default.
- W1965937109 hasConcept C126322002 @default.
- W1965937109 hasConcept C141071460 @default.
- W1965937109 hasConcept C179755657 @default.
- W1965937109 hasConcept C191897082 @default.
- W1965937109 hasConcept C192562407 @default.
- W1965937109 hasConcept C2777789703 @default.
- W1965937109 hasConcept C2778497195 @default.
- W1965937109 hasConcept C2779134260 @default.
- W1965937109 hasConcept C2908647359 @default.
- W1965937109 hasConcept C502230775 @default.
- W1965937109 hasConcept C71924100 @default.
- W1965937109 hasConcept C99454951 @default.
- W1965937109 hasConceptScore W1965937109C121608353 @default.
- W1965937109 hasConceptScore W1965937109C126322002 @default.
- W1965937109 hasConceptScore W1965937109C141071460 @default.
- W1965937109 hasConceptScore W1965937109C179755657 @default.
- W1965937109 hasConceptScore W1965937109C191897082 @default.
- W1965937109 hasConceptScore W1965937109C192562407 @default.
- W1965937109 hasConceptScore W1965937109C2777789703 @default.
- W1965937109 hasConceptScore W1965937109C2778497195 @default.
- W1965937109 hasConceptScore W1965937109C2779134260 @default.
- W1965937109 hasConceptScore W1965937109C2908647359 @default.
- W1965937109 hasConceptScore W1965937109C502230775 @default.
- W1965937109 hasConceptScore W1965937109C71924100 @default.
- W1965937109 hasConceptScore W1965937109C99454951 @default.
- W1965937109 hasLocation W19659371091 @default.
- W1965937109 hasLocation W19659371092 @default.
- W1965937109 hasLocation W19659371093 @default.
- W1965937109 hasLocation W19659371094 @default.
- W1965937109 hasOpenAccess W1965937109 @default.
- W1965937109 hasPrimaryLocation W19659371091 @default.
- W1965937109 hasRelatedWork W2018724029 @default.
- W1965937109 hasRelatedWork W2055939901 @default.
- W1965937109 hasRelatedWork W2064638057 @default.
- W1965937109 hasRelatedWork W2090900200 @default.
- W1965937109 hasRelatedWork W2149119736 @default.
- W1965937109 hasRelatedWork W2279766832 @default.
- W1965937109 hasRelatedWork W3108298832 @default.
- W1965937109 hasRelatedWork W3117633420 @default.
- W1965937109 hasRelatedWork W3211320611 @default.
- W1965937109 hasRelatedWork W4232271242 @default.
- W1965937109 hasVolume "19" @default.
- W1965937109 isParatext "false" @default.
- W1965937109 isRetracted "false" @default.
- W1965937109 magId "1965937109" @default.
- W1965937109 workType "article" @default.